Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -25.63%8.56M | 15.06%19.52M | 61.00%14.17M | -26.41%48.11M | -33.05%10.83M | -47.16%11.51M | 68.50%16.97M | -49.26%8.8M | 283.70%65.38M | 287.68%16.18M |
| Cost of revenue | -15.51%38.46M | 320.25%45.52M | ||||||||
| Gross profit | -25.63%8.56M | -51.39%9.65M | 11.51M | 219.92%19.86M | ||||||
| Operating expense | -42.92%6.41M | 11.72%18.74M | 66.32%13.89M | -37.49%8.9M | 15.85%20.34M | -47.15%11.22M | 73.26%16.77M | -45.39%8.35M | -11.56%14.24M | 9,820.98%17.55M |
| Selling and administrative expenses | ---- | ---- | ---- | -37.49%8.9M | ---- | ---- | ---- | ---- | 30.02%14.24M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -76.95%1.24M | ---- | ---- | ---- | ---- | 775.65%5.37M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -13.57%7.66M | ---- | ---- | ---- | ---- | -14.25%8.86M | ---- |
| Other operating expenses | -6.27%10.63M | 11.59%18.86M | 60.98%13.98M | -11.15%57.2M | 13.40%20.34M | -46.76%11.34M | 72.97%16.9M | -43.48%8.69M | 1,150.56%64.38M | 256.57%17.93M |
| Total other operating income | 3,392.56%4.23M | -4.62%124K | -72.46%92K | -15.66%517K | ---- | 75.36%121K | 42.86%130K | 351.35%334K | --613K | --379K |
| Operating profit | 645.67%2.16M | 303.08%786K | -37.47%282K | -86.59%754.37K | -590.77%-9.51M | -47.45%289K | -49.87%195K | -78.04%451K | 156.87%5.62M | 79.87%-1.38M |
| Net non-operating interest income (expenses) | -542.11%-488K | 0.75%-265K | 33.60%-166K | -94.65%-941.58K | -196.94%-349K | 73.33%-76K | -8.98%-267K | 20.38%-250K | 36.26%-483.74K | 495.84%360K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --360K |
| Non-operating interest expense | 542.11%488K | -0.75%265K | -33.60%166K | 94.65%941.58K | --349K | -73.33%76K | 8.98%267K | -20.38%250K | -36.26%483.74K | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -538.89%-79K | -24.05%60K | 4.48%70K | -28.48%227.84K | -15.79%64K | -79.55%18K | 5.33%79K | -16.25%67K | 2,197.40%318.56K | 129.67%76K |
| Special income (charges) | 0 | -97.29%7.24K | ||||||||
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 97.29%-7.24K | ---- |
| Other non-operating income (expenses) | -132.27%-9.32M | -625.35%-4.01M | ||||||||
| Income before tax | 587.45%1.59M | 8,200.00%581K | -30.60%186K | -739.26%-9.28M | -941.49%-9.79M | -34.56%231K | -96.80%7K | -85.27%268K | 115.12%1.45M | 84.72%-940K |
| Income tax | 237.79%581K | 0 | -56.04%40K | -50.45%1.21M | -37.36%944K | 142.25%172K | 0 | -89.43%91K | 477.95%2.44M | 327,708.70%1.51M |
| Net income | 1,606.78%1.01M | 8,200.00%581K | -17.51%146K | -966.00%-10.49M | -338.66%-10.73M | -79.08%59K | -96.85%7K | -81.54%177K | 90.18%-984.09K | 60.21%-2.45M |
| Net income continuous operations | 1,606.78%1.01M | 8,200.00%581K | -17.51%146K | -966.00%-10.49M | -338.66%-10.73M | -79.08%59K | -96.85%7K | -81.54%177K | 90.18%-984.09K | 60.21%-2.45M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 1,606.78%1.01M | 8,200.00%581K | -17.51%146K | -966.00%-10.49M | -338.66%-10.73M | -79.08%59K | -96.85%7K | -81.54%177K | 90.18%-984.09K | 60.21%-2.45M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1,606.78%1.01M | 8,200.00%581K | -17.51%146K | -966.00%-10.49M | -338.66%-10.73M | -79.08%59K | -96.85%7K | -81.54%177K | 90.18%-984.09K | 60.21%-2.45M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1,200.00%0.0013 | 0.0007 | 0.00%0.0002 | -914.29%-0.0142 | -314.29%-0.0145 | -80.00%0.0001 | 0 | -88.89%0.0002 | 93.24%-0.0014 | 69.03%-0.0035 |
| Diluted earnings per share | 1,200.00%0.0013 | 0.0007 | 0.00%0.0002 | -914.29%-0.0142 | -314.29%-0.0145 | -80.00%0.0001 | 0 | -88.89%0.0002 | 93.24%-0.0014 | 69.03%-0.0035 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.